Jazz Pharmaceuticals JAZZ
NASDAQ JAZZ
$231.52 -0.83 (-0.36%)
At close: Sep 30, 2026 · 4:00 PM EDT

Jazz Pharmaceuticals (JAZZ) Current Deferred Revenue (2010 - 2023)

Updated

Jazz Pharmaceuticals (JAZZ) posted Current Deferred Revenue of $4,000 for Q3 2023, down 99.5% from $871,000 a year earlier and unchanged from the prior quarter.

Analysis

Jazz Pharmaceuticals (JAZZ) Current Deferred Revenue (2010 - 2023) Analysis & Trends

At the end of FY2022, Jazz Pharmaceuticals' Current Deferred Revenue came in at $463,000, down 77.9% from FY2021.

  • Annual Current Deferred Revenue has declined for five consecutive years, with a five-year compound annual growth rate of -44.3% (FY2017 to FY2022).
  • In prior years, Jazz Pharmaceuticals' Current Deferred Revenue was $2.09 million in FY2021 (-17.8%), $2.55 million in FY2020 (-46.1%), $4.72 million in FY2019 (-12.8%) and $5.41 million in FY2018 (-37.2%).
  • Quarterly Current Deferred Revenue has run from a low of $4,000 in Q1 2023 to a high of $5.41 million in Q4 2018 over five years.
  • On a year-over-year basis, Current Deferred Revenue has declined in each of the last 23 quarters, with an average decline of 66.6% over the last eight quarters.
  • Across the past five years, year-over-year decline in Current Deferred Revenue ran from 11.5% in Q1 2020 to 99.8% in Q1 2023.
  • According to Business Quant data, Current Deferred Revenue for the three prior quarters was $4,000 (Q2 2023), $4,000 (Q1 2023) and $463,000 (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Jazz Pharmaceuticals 15.03 Bn 8.85 Bn 1.09 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 4,000.00
Jun 30, 2023 4,000.00
Mar 31, 2023 4,000.00
Dec 31, 2022 463,000.00
Sep 30, 2022 871,000.00
Jun 30, 2022 1.28 Mn
Mar 31, 2022 1.69 Mn
Dec 31, 2021 2.09 Mn
Sep 30, 2021 2.27 Mn
Jun 30, 2021 2.44 Mn
Mar 31, 2021 2.37 Mn
Dec 31, 2020 2.55 Mn
Sep 30, 2020 3.09 Mn
Jun 30, 2020 3.63 Mn
Mar 31, 2020 4.18 Mn
Dec 31, 2019 4.72 Mn
Sep 30, 2019 4.72 Mn
Jun 30, 2019 4.72 Mn
Mar 31, 2019 4.72 Mn
Dec 31, 2018 5.41 Mn
API Access

Jazz Pharmaceuticals Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=JAZZ&period=max&api_key=YOUR_API_KEY